Takeover Bids

More

• $7.1 Billion Pharma Deal  Monday, 2 Jul 2012 | 1:11 PM ET

  

  CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.

• Faber Report: Complications Arise in Fresenius-Rhoen Deal  Wednesday, 27 Jun 2012 | 9:41 AM ET

  

  CNBC's David Faber reports the latest details on the takeover deal between German health care company Fresenius and Rhoen-Klinikum.

• Deal Brewing Between Grupo Modelo and Anheuser  Monday, 25 Jun 2012 | 11:50 AM ET

  

  CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.

• Insight Working on Increasing Bid on Quest  Thursday, 14 Jun 2012 | 10:55 AM ET

  

  Insight Venture Partners is currently working on a revision of its bid for Quest Software, reports CNBC's Kayla Tausche.

• Markets Could Stay Volatile for 2 Years: Expert  Wednesday, 13 Jun 2012 | 11:40 PM ET

  

  Campbell Dawson, Portfolio Manager, Elstree Investment Management advises investors go into defensives and fixed-income, adding that the euro debt crisis could drag on another 2 years.

• Groupon's Rise & Missteps  Friday, 8 Jun 2012 | 11:40 AM ET

  

  Frank Sennett, "Groupon's Biggest Deal Ever" author, discusses Groupon's decision to decline Google's $6 billion bid back in 2010 and weighs in on the future of the deal-of-the-day company.

• Chesapeake Shakes Up Board  Monday, 4 Jun 2012 | 1:46 PM ET

  

  Four directors at Chesapeake Energy will resign from the company's board following discussions with Carl Icahn. CNBC's Kate Kelly has the details.

• Ahead of Groupon's Earnings  Monday, 14 May 2012 | 12:30 PM ET

  

  The FMHR traders share their top three trades of the hour, including shares of Avon moving higher on news it will consider Coty's takeover bid. Mark Mahaney, Citigroup internet analyst, also forecasts Groupon's earnings performance.

• Faber Report: Elliot Notifies BMC It Intends to Nominate 5 Board Members  Monday, 14 May 2012 | 9:43 AM ET

  

  CNBC's David Faber reports Elliot International notified BMC Software it intends to nominate a slate of five board members and billionaire investor Carl Icahn is ready to disclose his stake in Chesapeake Energy.

• Roadmap: Europe, Facebook & More  Thursday, 10 May 2012 | 9:00 AM ET

  

  The "Squawk on the Street" team discusses this morning's major headlines, including European stocks on the rebound, Coty's higher bid for Avon, and a new revelation from Facebook.

• P.F. Chang's Bought for $1.09B  Tuesday, 1 May 2012 | 1:25 PM ET

  

  CNBC's Tyler Mathisen reports shares of P.F. Chang's are moving higher on news the Chinese food chain is being bought by Centerbridge Partners. Jeff Kilburg, Kilburg Capital, weighs in on other takeover targets.

• What's Next for Carl Icahn?   Monday, 30 Apr 2012 | 4:14 PM ET

  

  CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.

• Human Genome Rejects GlaxoSmithKline's Bid  Thursday, 19 Apr 2012 | 12:41 PM ET

  

  Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.

• Illumina Plays Offense & Final Trade  Tuesday, 17 Apr 2012 | 12:55 PM ET

  

  CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.

• Faber Report: Illumina  Tuesday, 17 Apr 2012 | 9:42 AM ET

  

  CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.

• No Huddle Offense: RIMM & YHOO, Takeover Targets or Turnarounds?  Wednesday, 4 Apr 2012 | 6:58 PM ET

  

  Mad Money host Jim Cramer shares his final thoughts on the future of tech giants, Research in Motion and Yahoo.

• Why RIM is 'Cheap'  Wednesday, 4 Apr 2012 | 5:31 PM ET

  

  The play on Research in Motion, and whether it's a prime takeover target, with the Fast Money crew.

• No Huddle Offense: How to Save Avon, Cramer  Monday, 2 Apr 2012 | 6:58 PM ET

  

  Mad Money host Jim Cramer shares two things he thinks have to happen to save Avon: get rid of Jung, and ignore Coty's bid.

• Avon for Sale?  Monday, 2 Apr 2012 | 5:17 PM ET

  

  The Fast Money traders weigh in on how to play unusual options activity in Avon's shares on Monday.

• Groupon Revises Q4 & Full Year  Monday, 2 Apr 2012 | 3:09 PM ET

  

  CNBC's Brian Shactman breaks down today's big movers including two downgrades at Stifel Nicolaus, and Avon's rejection of a takeover bid from Coty.